"MRI offers an advantage over conventional methods in assessing recurrence. This can be seen in evaluating of tumour recurrence versus scarring where enhancement in the post-surgical scar should decrease substantially over the first 2 years. The presence of enhancement at the lumpectomy site after ~18 months since surgery is considered a concerning feature for recurrent breast cancer."
"MRI offers an advantage over conventional methods in assessing recurrence. This can be seen in evaluating of tumour recurrence versus scarring where enhancement in the post-surgical scar should decrease substantially over the first 2 years. The presence of enhancement at the lumpectomy site after ~18 months since surgery is considered a concerning feature for recurrent breast cancer."
Expected headings
"Risk factors"
"Breast MRI"